Compare DXR & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXR | CRT |
|---|---|---|
| Founded | 1970 | 1991 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 56.5M |
| IPO Year | 1995 | N/A |
| Metric | DXR | CRT |
|---|---|---|
| Price | $10.02 | $9.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.2K | ★ 26.2K |
| Earning Date | 02-27-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 5.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,446,345.00 | N/A |
| Revenue This Year | $44,935.22 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ $11.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.56 | $7.07 |
| 52 Week High | $14.76 | $11.10 |
| Indicator | DXR | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 29.56 |
| Support Level | $9.76 | $7.18 |
| Resistance Level | $11.44 | $9.07 |
| Average True Range (ATR) | 0.44 | 0.39 |
| MACD | 0.03 | -0.16 |
| Stochastic Oscillator | 43.17 | 23.23 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.